Average Co-Inventor Count = 6.71
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-La Roche Inc. (12 from 4,948 patents)
2. Telefonaktiebolaget Lm Ericsson (Publ) (3 from 25,797 patents)
3. 3M Innovative Properties Company (1 from 14,087 patents)
4. Schaeffler Technologies Ag & Co .Kg (1 from 3,794 patents)
5. Sika Technology Ag (1 from 645 patents)
6. F. Hoffmann-La Roche Ag (168 patents)
19 patents:
1. 12351575 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
2. 12264104 - Multi-component composition for manufacturing polyurethane/urea cementitious hybrid systems
3. 12247036 - Tricyclic compounds for the treatment of cancer
4. 11948258 - Remote monitoring method based on information fusion and virtual reality for marine engine room
5. 10823638 - Monitoring method and monitoring apparatus for determining remaining life of a bearing
6. 10428069 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
7. 10251209 - Smart 3GDT
8. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
9. 10081627 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
10. 9856247 - 4-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infection
11. 9758530 - 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
12. 9670211 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
13. 9447086 - 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
14. 9343893 - Device and method for field expansion
15. 9266904 - 6-bridged heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection